Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05157542
Status:
UNKNOWN
Last Update Posted:
2021-12-15
First Post:
2021-05-24
Brief Title:
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Sponsor:
Juan LI MD
Organization:
Sichuan Cancer Hospital and Research Institute
Organization Data
Organization:
Sichuan Cancer Hospital and Research Institute
Class:
OTHER
Study ID:
EK2021001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Juan LI MD
Lead Sponsor Class:
OTHER
Responsible Party:
Juan LI MD
Responsible Party Title:
director of a department of medical oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Sichuan Cancer Hospital and Research Institute
Old Name:
None
Old Organization:
None